PTN (PTN) Stock Price & Analysis
PTN (PTN) fell 2.90% to USD 12.7 as of September 8, 2026 at 09:35 UTC, according to Nexqual real-time market data.
PTN last closed at USD 12.7; the session ranged USD 12.55–13.48 on volume of 257,715 shares. Market capitalization is —, with a 52-week range of USD 5.61–31 (NCM). Source: Nexqual, September 8, 2026 at 09:35 UTC.
Key Statistics (as of September 8, 2026 at 09:35 UTC)
| Price | USD 12.7 |
|---|---|
| Change | ▼ 2.90% (down) |
| Previous Close | USD 12.7 |
| Open | USD 12.7 |
| Day Range | USD 12.55 – 13.48 |
| 52-Week Range | USD 5.61 – 31 |
| Volume | 257,715 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (PTN)
Nexqual's technical model rates PTN "BUY" based on 5 bullish and 1 bearish signals across 128 daily candles, as of September 8, 2026 at 09:35 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 70.11 (overbought) |
| vs SMA50 | Above (USD 9.56) |
| MACD | 0.83 (positive) |
From PTN's Latest SEC 10-K Filing (filed 2025-09-23)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| MBIO | Mustang Bio, Inc. | USD 0.54 | ▼ 0.02% |
| OGEN | Oragenics Inc. | USD 0.51 | ▲ 0% |
| JAGX | Jaguar Health, Inc. | USD 0.6 | ▼ 18.25% |
| TNXP | Tonix Pharmaceuticals Holding C | USD 13.14 | ▼ 1.79% |
| ATOS | Atossa Therapeutics, Inc. | USD 2.52 | ▲ 2.44% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 09:35 UTC. This page is informational and not investment advice.